{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:47:33Z","timestamp":1787870853568,"version":"build-2784847793"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T00:00:00Z","timestamp":1576540800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T00:00:00Z","timestamp":1576540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s12149-019-01431-z","type":"journal-article","created":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T10:23:17Z","timestamp":1576578197000},"page":"87-93","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Diagnosis of cardiac sarcoidosis: an era of paradigm shift"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7419-9652","authenticated-orcid":false,"given":"Apurva","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harout","family":"Yacoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Chrispin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabahat","family":"Bokhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,17]]},"reference":[{"key":"1431_CR1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1001\/jama.2011.10","volume":"305","author":"MC Iannuzzi","year":"2011","unstructured":"Iannuzzi MC, Fontana JR. Sarcoidosis: clinical presentation, immunopathogenesis and therapeutics. JAMA. 2011;305:391\u20139.","journal-title":"JAMA"},{"key":"1431_CR2","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1001\/archinte.1929.00140050098009","volume":"44","author":"M Bernstein","year":"1929","unstructured":"Bernstein M, Konzlemann F, Siddlik D. Boeck\u2019s Sarcoid: report of a case with visceral involvement. Arch Intern Med. 1929;44:721\u201334.","journal-title":"Arch Intern Med"},{"key":"1431_CR3","unstructured":"Hillerdal O., Niou E., Osterman K.Sarcoidosis. Epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis. 1984;130:29\u201332"},{"key":"1431_CR4","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/oxfordjournals.aje.a009096","volume":"145","author":"BA Rybicki","year":"1997","unstructured":"Rybicki BA, Major M, Popovich J Jr, et al. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997;145:234\u201341.","journal-title":"Am J Epidemiol."},{"issue":"1","key":"1431_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005792-195202000-00001","volume":"31","author":"WT Longcope","year":"1952","unstructured":"Longcope WT, Freiman DG. A study of sarcoidosis; based on a combined investigation of 160 cases including 30 autopsies from The Johns Hopkins Hospital and Massachusetts General Hospital. Medicine (Baltimore). 1952;31(1):1\u2013132.","journal-title":"Medicine (Baltimore)"},{"key":"1431_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/0002-9343(77)90121-8","volume":"63","author":"WC Roberts","year":"1977","unstructured":"Roberts WC, McAllister HA Jr, Ferrans VJ. Sarcoidosis of the heart: a clinicopathologic study of 35 necropsy patients (group I) and review of 78 previously described necropsy patients (group II). Am J Med. 1977;63:86\u2013108.","journal-title":"Am J Med"},{"key":"1431_CR7","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/S0140-6736(03)12888-7","volume":"361","author":"RP Baughman","year":"2003","unstructured":"Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet. 2003;361:1111\u20138.","journal-title":"Sarcoidosis. Lancet"},{"key":"1431_CR8","first-page":"1438","volume":"52","author":"Y Hiraga","year":"1994","unstructured":"Hiraga Y. An epidemiological study of clustering of sarcoidosis cases. Nippon Rinsho. 1994;52:1438\u201342.","journal-title":"Nippon Rinsho."},{"key":"1431_CR9","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1136\/thx.43.4.342","volume":"43","author":"WM Edmondstone","year":"1988","unstructured":"Edmondstone WM. Sarcoidosis in nurses: is there an association? Thorax. 1988;43:342\u20133.","journal-title":"Thorax"},{"key":"1431_CR10","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/0895-4356(88)90060-1","volume":"44","author":"TH Hennessy","year":"1988","unstructured":"Hennessy TH, Ballard DJ, DeRemee RA, et al. The influence of diagnostic access bias on the epidemiology of sarcoidosis: a population-based study in Rochester, Minnesota, 1935\u20131984. J Clin Epidemiol. 1988;44:565\u201370.","journal-title":"J Clin Epidemiol."},{"issue":"4","key":"1431_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jacc.2016.03.605","volume":"68","author":"DH Birnie","year":"2016","unstructured":"Birnie DH, Nery PB, Ha AC, et al. Cardiac Sarcoidosis. J Am Coll Cardiol. 2016;68(4):11\u201321.","journal-title":"J Am Coll Cardiol."},{"issue":"8","key":"1431_CR12","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/jce.12401","volume":"25","author":"PB Nery","year":"2014","unstructured":"Nery PB, Beanlands RS, Nair GM, et al. Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults. J Cardiovasc Electrophysiol. 2014;25(8):875\u201381.","journal-title":"J Cardiovasc Electrophysiol."},{"issue":"7","key":"1431_CR13","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","volume":"131","author":"R Kandolin","year":"2015","unstructured":"Kandolin R, Lehtonen J, Airaksinen J, et al. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation. 2015;131(7):624\u201332.","journal-title":"Circulation"},{"issue":"9","key":"1431_CR14","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S0002-9149(01)01978-6","volume":"88","author":"Y Yazaki","year":"2001","unstructured":"Yazaki Y, Isobe M, Hiroe M, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol. 2001;88(9):1006\u2013100.","journal-title":"Am J Cardiol."},{"key":"1431_CR15","unstructured":"Guideline for Diagnosis of Cardiac Sarcoidosis: Study Report on Diffuse Pulmonary Diseases. Tokyo Japan: Ministry of Health, Labour and Welfare, 1993:23\u20134"},{"key":"1431_CR16","first-page":"89","volume":"27","author":"Diagnostic standard and guidelines for sarcoidosis","year":"2007","unstructured":"Diagnostic standard and guidelines for sarcoidosis. Jpn J Sarcoidosis Granulomatous Disord. 2007;27:89\u2013102.","journal-title":"Jpn J Sarcoidosis Granulomatous Disord"},{"issue":"20","key":"1431_CR17","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1161\/CIRCULATIONAHA.109.851352","volume":"120","author":"Manesh R. Patel","year":"2009","unstructured":"Patel MR, Cawley PJ, MD, Heitner JF et al. Detection of myocardial damage in patients with sarcoidosis. Circulation. 2009; 120(20):1969\u20131977.","journal-title":"Circulation"},{"key":"1431_CR18","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","volume":"11","author":"DH Birnie","year":"2014","unstructured":"Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11:1305\u201323.","journal-title":"Heart Rhythm"},{"key":"1431_CR19","first-page":"19","volume":"31","author":"MA Judson","year":"2014","unstructured":"Judson MA, Costabel U, Drent M, et al. The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis. 2014;31:19\u201327.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"1431_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.17996\/anc.17-00042","volume":"3","author":"F Terasaki","year":"2017","unstructured":"Terasaki F, Yoshinaga K. New Guidelines for the diagnosis of Cardiac sarcoidosis in Japan. Ann Nucl Cardiol. 2017;3:42\u20135.","journal-title":"Ann Nucl Cardiol."},{"key":"1431_CR21","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s12350-017-0978-9","volume":"24","author":"P Chareonthaitawee","year":"2017","unstructured":"Chareonthaitawee P, Beanlands RS, Chen W, et al. Joint SNMMI\u2013ASNC expert consensus document on the role of 18F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Cardiol. 2017;24:1741.","journal-title":"J Nucl Cardiol"},{"key":"1431_CR22","doi-asserted-by":"crossref","unstructured":"Kumita S, Yoshinaga K, Miyagawa M, et al. Recommendations for 18-Fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac sarcoidosis-2018 update: Japanese Society of Nuclear Cardiology recommendations. J Nucl Cardiol. 2019. 10.1007\/s12350\u2013019\u201301755\u20133. [Epub ahead of print]","DOI":"10.1007\/s12350-019-01755-3"},{"key":"1431_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12016-014-8450-y","volume":"49","author":"MA Judson","year":"2015","unstructured":"Judson MA. The Clinical Features of Sarcoidosis: A Comprehensive Review. Clinic Rev Allerg Immunol. 2015;49:63.","journal-title":"Clinic Rev Allerg Immunol"},{"key":"1431_CR24","unstructured":"Judson MA. The diagnosis of sarcoidosis. Curr Opin Pulm Med.2019. 10.1097\/MCP.0000000000000596. [Epub ahead of print]"},{"issue":"1","key":"1431_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ahj.2008.09.009","volume":"157","author":"Jessica S. Kim","year":"2009","unstructured":"Kim JS,BS, Judson MA, Donnino R, et al. Cardiac sarcoidosis. Am Heart J. 2009;157(1):9\u201321.","journal-title":"American Heart Journal"},{"issue":"6","key":"1431_CR26","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/01.md.0000145367.17934.75","volume":"83","author":"C Chapelon-Abric","year":"2004","unstructured":"Chapelon-Abric C, de Zuttere D, Duhaut P. Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine. 2004;83(6):315\u201334.","journal-title":"Medicine."},{"key":"1431_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijcard.2015.03.175","volume":"189","author":"S Nagao","year":"2015","unstructured":"Nagao S, Watanabe H, Sobue Y, et al. Electrocardiographic abnormalities and risk of developing cardiac events in extracardiac sarcoidosis. Int J Cardiol. 2015;189:1\u20135.","journal-title":"Int J Cardiol."},{"key":"1431_CR28","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1111\/echo.13281","volume":"33","author":"G Murtagh","year":"2016","unstructured":"Murtagh G, Laffin LJ, Patel KV, et al. Improved detection of myocardial damage in sarcoidosis using longitudinal strain in patients with preserved left ventricular ejection fraction. Echocardiography. 2016;33:1344\u201352.","journal-title":"Echocardiography."},{"issue":"7","key":"1431_CR29","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1177\/000331979004100711","volume":"41","author":"EL Kinney","year":"1990","unstructured":"Kinney EL, Caldwell JW. Do thallium myocardial perfusion scan abnormalities predict survival in sarcoid patients without cardiac symptoms? Angiology. 1990;41(7):573\u20136.","journal-title":"Angiology"},{"key":"1431_CR30","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1378\/chest.107.2.330","volume":"107","author":"K Okayama","year":"1995","unstructured":"Okayama K, Kurata C, Tawarahara K, et al. Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in Cardiac Sarcoidosis. Chest. 1995;107:330\u20134.","journal-title":"Chest"},{"issue":"4","key":"1431_CR31","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1378\/chest.126.4.1372","volume":"126","author":"A Nakazawa","year":"2004","unstructured":"Nakazawa A, Ikeda K, Ito Y, et al. Usefulness of dual Ga-67 and Tc-99m-Sestamibi single-photon-emission CT scanning in the diagnosis of cardiac sarcoidosis. Chest. 2004;126(4):1372\u20136.","journal-title":"Chest"},{"key":"1431_CR32","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1161\/CIRCHEARTFAILURE.112.000087","volume":"6","author":"MK Bennett","year":"2013","unstructured":"Bennett MK, Gilotra NA, Harrington C, et al. Evaluation of the role of endomyocardial biopsy in 851 patients with unexplained heart failure from 2000\u20132009. Cir Heart Fail. 2013;6:676\u201384.","journal-title":"Cir Heart Fail."},{"issue":"5","key":"1431_CR33","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.jchf.2014.03.015","volume":"2","author":"JJ Liang","year":"2014","unstructured":"Liang JJ, Hebl VB, DeSimone CV, et al. Electrogram guidance: a method to increase the precision and diagnostic yield of endomyocardial biopsy for suspected cardiac sarcoidosis and myocarditis. JACC Heart Fail. 2014;2(5):466\u201373.","journal-title":"JACC Heart Fail."},{"issue":"5","key":"1431_CR34","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1365-2796.2011.02396.x","volume":"270","author":"R Kandolin","year":"2011","unstructured":"Kandolin R, Lehtonen J, Graner M, et al. Diagnosing isolated cardiac sarcoidosis. J Intern Med. 2011;270(5):461\u20138.","journal-title":"J Intern Med."},{"issue":"2","key":"1431_CR35","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2967\/jnumed.111.090662","volume":"53","author":"G Youssef","year":"2012","unstructured":"Youssef G, Leung E, Mylonas I, et al. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and meta-analysis including the Ontario experience. J Nucl Med. 2012;53(2):241\u20138.","journal-title":"J Nucl Med."},{"key":"1431_CR36","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1161\/CIRCULATIONAHA.109.851352","volume":"120","author":"MR Patel","year":"2009","unstructured":"Patel MR, Cawley PJ, Heitner JF, et al. Detection of myocardial damage in patients with sarcoidosis. Circulation. 2009;120:1969\u201377.","journal-title":"Circulation"},{"key":"1431_CR37","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.jcmg.2016.11.019","volume":"10","author":"V Kouranos","year":"2017","unstructured":"Kouranos V, Tzelepis GE, Rapti A, et al. Complementary role of CMR to conventional screening in the diagnosis and prognosis of cardiac sarcoidosis. J Am Coll Cardiol Img. 2017;10:1437\u201347.","journal-title":"J Am Coll Cardiol Img."},{"key":"1431_CR38","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s11886-013-0370-6","volume":"15","author":"H Skali","year":"2013","unstructured":"Skali H, Schulman AR, Dorbala S. 18-F-FDG PET\/CT for the assessment of myocardial sarcoidosis. Curr Cardiol Rep. 2013;15:370.","journal-title":"Curr Cardiol Rep."},{"issue":"7","key":"1431_CR39","first-page":"1030","volume":"44","author":"H Yamagishi","year":"2003","unstructured":"Yamagishi H, Shirai N, Takagi M, et al. Identification of cardiac sarcoidosis with (13)N-NH(3)\/(18)F-FDG PET. J Nucl Med. 2003;44(7):1030\u20136.","journal-title":"J Nucl Med."},{"key":"1431_CR40","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s12350-013-9828-6","volume":"21","author":"MT Osborne","year":"2014","unstructured":"Osborne MT, Hulten EA, Singh A, et al. Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis. J Nucl Cardiol. 2014;21:166\u201374.","journal-title":"J Nucl Cardiol."},{"issue":"7","key":"1431_CR41","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/ehjci\/jex340","volume":"19","author":"EC Wicks","year":"2018","unstructured":"Wicks EC, Menezes LJ, Barnes A, et al. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography\/magnetic resonance imaging in cardiac sarcoidosis. Eur Heart J Cardiovasc Imaging. 2018;19(7):757\u201367.","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"1431_CR42","doi-asserted-by":"publisher","first-page":"e007030","DOI":"10.1161\/CIRCIMAGING.117.007030","volume":"11","author":"T Vita","year":"2018","unstructured":"Vita T, Okada DR, Veillet-Chowdhury M, et al. Complimentary value of cardiac magnetic resonance imaging and positron emission tomography\/computed tomography in the assessment of cardiac sarcoidosis. Circ Cardiovasc Imaging. 2018;11:e007030.","journal-title":"Circ Cardiovasc Imaging."}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-019-01431-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-019-01431-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-019-01431-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T01:20:43Z","timestamp":1608081643000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-019-01431-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,17]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["1431"],"URL":"https:\/\/doi.org\/10.1007\/s12149-019-01431-z","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,17]]},"assertion":[{"value":"1 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Sabahat Bokhari is on advisory board for Pfizer and speaker for Pfizer and Astellas. Rest of the authors have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}